ARCHIVES

Proflavine Bioassay Ineffective, NCI Says

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995